ISG15 and breast cancer: In addition, elevated expression of ISG15 suppresses camptothecin-induced proteasome-mediated degradation of topoisomerase I in breast cancer cells [34], further supporting the antagonistic role of ISG15 in ubiquitin-mediated degradation of many endogenous cellular proteins.